Market Research Logo

Autoinjectors Market Forecast up to 2024

Autoinjectors Market Forecast up to 2024

Autoinjectors Market – Global Drivers, Restraints, Opportunities, Trends, and Forecast: 2018–2024
Overview: The medical devices that are primarily used for the self-injection of drugs, classically life-saving drugs, are known as autoinjectors. These devices are gaining increased importance for the management of anaphylaxis, diabetes, rheumatoid arthritis, multiple sclerosis, and others. Autoinjectors are relaxed to use and proposed for self-administration by individuals either at caretakers premises or at home.
Raising prevalence of serious medical conditions such as anaphylaxis & other food allergies, advancements in the autoinjectors technology, increasing demand for home healthcare, and the rising need for self-injectors are the factors aiding the growth of the autoinjectors market. Novel formulations of drugs and advancements in drug delivery systems along with favorable government regulations are providing an opportunity for the market growth. However, recent product recalls by the companies and the availability of substitutes for autoinjectors are hampering the market growth.
Market Analysis: The “global autoinjectors market” is estimated to witness a CAGR of 17.1% during the forecast period 2018–2024. The autoinjectors market is analyzed based on three segments – products, applications, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the autoinjectors market, followed by Europe, Asia Pacific, and Rest of the World. More than 65% of the market is occupied by North America, with the US being the major contributor to the market growth.
Product Analysis: Based on the products, the market is segmented into disposable autoinjectors and reusable autoinjectors. Disposable autoinjectors hold dominant market share and is also the fastest growing segment in the market.
Application Analysis: Based on the application areas, the market is segmented into anaphylaxis, multiple sclerosis, rheumatoid arthritis, diabetes, and others. The market is dominated by anaphylaxis owing to a high prevalence rate globally. The fastest growing segment of the market is rheumatoid arthritis due to increased development of novel drugs for the treatment of the condition.
Key Players: The major players in the market are Mylan NV, Novartis AG, Amgen, Inc., Becton Dickinson and Company, Bayer AG, and Eli Lilly & Company Ltd. The other key players in the market include Ypsomed Holding AG, Biogen Pharmaceuticals, Pfizer Inc., Teva Pharmaceutical, Antares Pharma, Inc., Johnson and Johnson, and AbbVie, Inc.
Competitive Analysis: The key manufacturers of autoinjectors are concentrating on innovative marketing tactics to expand the reach of their products globally. Increasing awareness campaigns and price reduction of branded devices are among the strategies used by the leading companies to manage intense competition in the market. Many companies are rebranding their autoinjectors with worthwhile reductions in the price. In December 2016, Mylan launched the generic version of EpiPen to provide autoinjector for customers at lesser prices. This approach ought to help the company in targeting a larger customer pool, thus increasing the company’s customer base in recent years.
Benefits: The report provides complete details about the usage and adoption rate of autoinjectors in various regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:


1 Industry Outlook
1.1 Industry Overview
1.2 Total Addressable Market
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Segmented Addressable Market
3.3 Industry Trends
3.4 Related Markets
3.4.1 Transdermal Drug Delivery
3.4.1.1 Trends of cardiovascular drugs market
3.4.2 Pulmonary Drug Delivery Systems (PDDS)
3.4.3 Insulin Pumps
4 Market Outlook
4.1 Cost comparison of EpiPen and its Alternatives
4.2 Market Segmentation
4.3 Porter 5(Five) Forces
4.4 PEST Analysis
5 Market Characteristics
5.1 Market Dynamics
5.1.1 Drivers
5.1.1.1 Increasing prevalence of Anaphylaxis
5.1.1.2 Rising incidence of chronic disease
5.1.1.3 Increased Development Biologics / Biosimilars
5.1.1.4 Growing demand for home care
5.1.2 Opportunities
5.1.2.1 Increase in healthcare spending
5.1.2.2 Opportunities in emerging market
5.1.2.3 Favorable government policies
5.1.3 Restraints
5.1.3.1 Competition among major vendors
5.1.3.2 Increased product recall
5.1.3.3 High product pricing
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 Application: Market Size and Analysis
6.1 Overview
6.2 Anaphylaxis
6.3 Multiple Sclerosis
6.4 Rheumatoid Arthritis
6.5 Diabetes
6.6 Others
7 Product Type: Market Size and Analysis
7.1 Overview
7.2 Disposable autoinjector
7.3 Reusable autoinjectors
8 Regions: Market Size and Analysis
8.1 Overview
8.2 North America
8.2.1 Overview
8.3 Europe
8.3.1 Overview
8.4 Asia Pacific
8.4.1 Overview
8.5 Rest of the World
8.5.1 Overview
9 Competitive Landscape
10 Vendors Profile
10.1 Amgen Inc.
10.1.1 Overview
10.1.2 Geographic Presence
10.1.3 Business Focus
10.1.4 SWOT Analysis
10.1.5 Business Strategies
10.2 Becton Dickinson and Company
10.2.1 Overview
10.2.2 Business Units
10.2.3 Geographic Revenue
10.2.4 Business Focus
10.2.5 SWOT Analysis
10.2.6 Business Strategies
10.3 Mylan N.V.
10.3.1 Overview
10.3.2 Business Segments
10.3.3 Geographic Presence
10.3.4 Business Focus
10.3.5 SWOT Analysis
10.3.6 Business Strategies
10.4 Bayer AG
10.4.1 Overview
10.4.2 Business Units
10.4.3 Geographic Presence
10.4.4 Business Focus
10.4.5 SWOT Analysis
10.4.6 Business Strategies
10.5 Eli Lilly & Company Ltd.
10.5.1 Overview
10.5.2 Business Units
10.5.3 Geographic Revenue
10.5.4 Business Focus
10.5.5 SWOT Analysis
10.5.6 Business Strategies
10.6 Novartis AG
10.6.1 Overview
10.6.2 Business Units
10.6.3 Geographic Presence
10.6.4 Business Focus
10.6.5 SWOT Analysis
10.6.6 Business Strategies
1 Vendors Profile
1.1 Ypsomed Holding AG
1.1.1 Overview
1.2 Biogen Pharmaceuticals
1.2.1 Overview
1.3 Pfizer Inc.
1.3.1 Overview
1.3.2 Highlights
1.4 Teva Pharmaceutical Industries Ltd.
1.4.1 Overview
1.5 Antares Pharma, Inc.
1.5.1 Overview
1.6 Johnson & Johnson
1.6.1 Overview
1.7 AbbVie Inc.
1.7.1 Overview
2 Annexure
Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report